Company: APM
Filing Date: 2025-12-05
Form Type: 424B5
Source: 0001213900-25-118752
Chunk: 342

Company: Aptorum Group Ltd
Filing Date: 2025-12-05
Form: 424B5
Chunk 342
---
 services to pre-IPO
and smaller reporting public companies with respect to accounting, financial reporting, and internal controls. Since November 2022, Mr.
Anthony has served the Company as a financial consultant and Acting Chief Financial Officer. Since 2022, Mr. Anthony has primarily
provided interim controller and financial reporting services to various such companies in pharmaceutical, software, manufacturing, and
service industries. From 2020 to 2022 he served as Controller of IPKeys Power Partners and from 2019 to 2020 Controller of Heat Biologics.
Previously, he served as Chief Financial Officer of Algos Pharmaceutical Corporation and Axion International and principal accounting
officer of Majesco Entertainment and Xenomics. Mr. Anthony earned his BS in Accounting from Monmouth College and initially served
on the audit staff of Coopers & Lybrand.

<div align='center'>197</div>

Significant Employees

The following are employees who are not executive officers, but who are expected to make significant contributions to Diamir’s business:

Gyanendra Kumar, PhD, VP, Assay Development. Dr. Kumar joined DiamiR in April 2021, and is an accomplished research & development leader, with experience
in leading CLIA facility operations. Dr. Kumar has 20+ years of experience in the development of technologies for molecular diagnostic
and other applications. Prior to joining DiamiR, he was VP of Assay Development at Interpace Biosciences. From 2014 to 2021, he led the
completion of product development, validation, and launch of two molecular diagnostic tests for thyroid malignancy based upon Next Generation
Sequencing and microRNA profiling. From 1999 to 2009, Dr. Kumar led R&D efforts for the development of whole genome amplification
(WGA) technologies at Molecular Staging and at GE Healthcare. Furthermore, he has expertise and record of establishing independent research
programs related to “Expression Regulation and Functional Genomics”. Prior to joining biotechnology industry, Dr. Kumar was
Associate Professor of Molecular Biology & Genetics (1988-1996) at Wayne State University School of Medicine, Detroit MI. He received
his post-doc training in Molecular Biology and Genetics from Prof. David C. Ward at Yale University, and Ph.D. in Chemistry from Lucknow
University, India.

Kenny K. Ablordeppey, MS, Laboratory Supervisor & Project Manager. Mr. Ablordeppey joined DiamiR in April 202